Research Article

Low Distribution of TIM-3+ Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors

Table 2

Correlation of TIM-3+, Gal-9+, CD8+, and CD56+ TIL densities with clinicopathological characteristics.

CharacteristicsTIM-3+ valueGal-9+ valueCD8+ valueCD56+ value
LowHighLowHighLowHighLowHigh

Age (years)0.4410.8730.0350.283
 ≤599072768697659369
 >597067637498398750
Gender0.6680.5080.4650.827
 Male88737289108539665
 Female7266677187518454
Modified NIH criteria<0.0001<0.0001<0.00010.001
 Low risk4770714660575562
 Intermediate risk2423232435123116
 High risk89464590100359441
Tumor size<0.00010.0090.0040.004
 ≤5 cm5677736075586865
 >5 cm10462661001204611254
Tumor site0.4190.088<0.00010.153
 Stomach937476911244310859
 Small bowel4551524442545046
 Colon43345234
 Others18118212451910
Mitoses per 50 HPFs<0.00010.0350.0010.004
 ≤592106102961158310890
 5-102420143032122717
 ≥10441323344894512
Tumor bleeding0.6790.9130.8570.339
 Yes2726252834193518
 No13311311413216185145101
Ki67 classification0.0990.0300.3570.275
 I101103991051287611787
 II2518241929142716
 III3418163638143616
Recurrence state0.038<0.0001<0.00010.078
 Yes412216475584419
 No11911712311314096136100
Local invasion0.0800.0410.0280.016
 Yes3721203845134315
 No12311811912215091137104

Abbreviations: HPF, high power field. Note: The values in bold type are those with statistical significance ().